Table 4
Top five prescription medications used, by sex, age group and medication class, household population aged 25 to 79, Canada, 2007 to 2011
Age group, medication class | Number '000 | Prevalence | ||
---|---|---|---|---|
% | 95% confidence interval | |||
from | to | |||
Men | ||||
Total 25 to 79 | ||||
Lipid-modifying agents, plain | 1,697.6 | 15.9Note * | 14.0 | 17.7 |
Ace inhibitors, plain | 978.1 | 9.1Note * | 7.6 | 10.7 |
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | 836.3 | 7.8 | 6.1 | 9.5 |
Beta-blocking agents | 730.3 | 6.8Note * | 5.6 | 8.1 |
Other analgesics and anti-pyretics | 677.7 | 6.3Note * | 5.4 | 7.3 |
25 to 44 | ||||
Anti-depressants | 190.8Note E: Use with caution | 4.2Note * | 2.4 | 6.0 |
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | 163.9Note E: Use with caution | 3.6 | 1.9 | 5.4 |
Adrenergics, Inhalants | 89.9Note E: Use with caution | 2.0 | 0.8 | 3.2 |
Lipid-modifying agents, plain | <149.2Note † | <3.3Note † | Note ...: not applicable | Note ...: not applicable |
Ace inhibitors, plain | 77.1Note E: Use with caution | 1.7Note * | 0.9 | 2.5 |
45 to 64 | ||||
Lipid-modifying agents, plain | 877.0 | 18.9Note * | 15.7 | 22.0 |
Ace inhibitors, plain | 477.7 | 10.3Note * | 7.8 | 12.7 |
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | 421.7Note E: Use with caution | 9.1 | 5.9 | 12.2 |
Anti-depressants | 381.9 | 8.2 | 5.6 | 10.9 |
Other analgesics and anti-pyretics | 364.7 | 7.8Note * | 6.1 | 9.6 |
65 to 79 | ||||
Lipid-modifying agents, plain | 738.7 | 47.9Note * | 42.0 | 53.7 |
Ace inhibitors, plain | 422.7 | 27.4Note * | 21.5 | 33.3 |
Beta-blocking agents | 359.7 | 23.3Note * | 17.8 | 28.9 |
Other analgesics and anti-pyretics | 281.7 | 18.3 | 14.5 | 22.0 |
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | 250.7 | 16.3 | 11.5 | 21.0 |
Women | ||||
Total 25 to 79 | ||||
Anti-depressants | 1,514.0 | 13.7Note * | 11.3 | 16.1 |
Lipid-modifying agents, plain | 1,205.2 | 10.9 | 9.3 | 12.5 |
Thyroid | 1,082.5 | 9.8Note * | 8.3 | 11.3 |
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | 1,011.8 | 9.2 | 7.5 | 10.8 |
Ace inhibitors, plain | 659.6 | 6.0 | 4.9 | 7.1 |
25 to 44 | ||||
Systemic use hormonal contraceptives | 513.1 | 11.4Note * | 8.5 | 14.3 |
Anti-depressants | 415.2 | 9.3Note E: Use with caution | 6.0 | 12.5 |
Thyroid | 194.5 | 4.3Note *Note E: Use with caution | 2.6 | 6.1 |
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | 119.1 | 2.7Note E: Use with caution | 1.4 | 3.9 |
Adrenergics, inhalants | 105.3 | 2.3Note E: Use with caution | 1.5 | 3.2 |
N03A | 89.1 | 2.0 | 0.2 | 3.7 |
B03A | 62.6 | 1.4 | 0.6 | 2.2 |
45 to 64 | ||||
Anti-depressants | 846.4 | 17.2Note * | 14.3 | 20.2 |
Lipid-modifying agents, plain | 563.9 | 11.5 | 8.8 | 14.2 |
Thyroid | 536.7 | 10.9Note * | 8.5 | 13.4 |
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | 522.2 | 10.6 | 8.0 | 13.2 |
Estrogens | 325.9 | 6.6Note * | 4.9 | 8.4 |
C09A | 323.8 | 6.6 | 4.7 | 8.5 |
N03A | 255.6 | 5.2 | 2.8 | 7.6 |
65 to 79 | ||||
Lipid-modifying agents, plain | 584.7 | 35.6 | 30.6 | 40.6 |
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | 370.4 | 22.5 | 17.6 | 27.4 |
Thyroid | 351.2 | 21.4Note * | 16.9 | 25.8 |
Ace inhibitors, plain | 304.9 | 18.5 | 14.4 | 22.7 |
Beta-blocking agents | 275.3 | 16.7 | 12.7 | 20.8 |
... not applicable E use with caution
Note: Respondents taking more than one drug in medication class are reflected in that class only once. Source: 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey, combined. |
- Date modified: